Serina Therapeutics, Inc. (SER) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $59.0K | +168.2% |
| 2024 | $22.0K | — |
| 2020 | $20.0K | -96.9% |
| 2019 | $641.0K | +2952.4% |
| 2018 | $21.0K | +2000.0% |
| 2017 | $1.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $59.0K | +168.2% |
| 2024 | $22.0K | — |
| 2020 | $20.0K | -96.9% |
| 2019 | $641.0K | +2952.4% |
| 2018 | $21.0K | +2000.0% |
| 2017 | $1.0K | — |